The survey on cellular and engineered tissue therapies in Europe in 2009.
暂无分享,去创建一个
Ivan Martin | Jakob Passweg | I. Martin | H. Baldomero | J. Passweg | I. Slaper-Cortenbach | A. Tyndall | C. Bocelli-Tyndall | Alan Tyndall | Helen Baldomero | Chiara Bocelli-Tyndall | Ineke Slaper-Cortenbach
[1] A. Uccelli,et al. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks , 2009, Bone Marrow Transplantation.
[2] Joshua M Hare,et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[3] F. Locatelli,et al. Mesenchymal Stromal Cells , 2009, Annals of the New York Academy of Sciences.
[4] Edward A Copelan,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[5] Yi Lin,et al. Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease , 2011, Advances in hematology.
[6] Xiaobing Fu,et al. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions , 2009, Cell and Tissue Research.
[7] T. Ben-Hur,et al. The changing face of neural stem cell therapy in neurologic diseases. , 2008, Archives of neurology.
[8] U. Schneider,et al. Indikations- und Durchführungsempfehlungen der Arbeitsgemeinschaft „Geweberegeneration und Gewebeersatz” zur Autologen Chondrozyten-Transplantation (ACT) , 2004 .
[9] Sabine Werner,et al. Keratinocyte-fibroblast interactions in wound healing. , 2007, The Journal of investigative dermatology.
[10] Hong Wang,et al. Extended Report , 2022 .
[11] D. Saris,et al. Patient Profiling in Cartilage Regeneration: Prognostic Factors Determining Success of Treatment for Cartilage Defects , 2009, The American journal of sports medicine.
[12] D. García-Olmo,et al. Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula: a Phase II Clinical Trial , 2009, Diseases of the colon and rectum.
[13] Lingyun Sun,et al. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE , 2010, Nature Reviews Rheumatology.
[14] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[15] A. Tyndall. Successes and failures of stem cell transplantation in autoimmune diseases. , 2011, Hematology. American Society of Hematology. Education Program.
[16] Ivan Martin,et al. Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. , 2009, Trends in biotechnology.
[17] P. Doevendans,et al. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. , 2011, Cardiovascular research.
[18] D. Hommes,et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study , 2010, Gut.
[19] D. Saris,et al. Treatment Selection in Articular Cartilage Lesions of the Knee , 2009, The American journal of sports medicine.
[20] Amit N. Patel,et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis , 2009, Journal of Translational Medicine.
[21] F. Appelbaum,et al. Hematopoietic-cell transplantation at 50. , 2007, The New England journal of medicine.
[22] T. Asahara,et al. Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.
[23] Dandan Wang,et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[24] S MacNeil,et al. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. , 2010, Experimental cell research.
[25] A. Ghavamzadeh,et al. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. , 2007, Iranian journal of immunology : IJI.
[26] A. Gratwohl,et al. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT). , 1994, Bone marrow transplantation.
[27] Robert Zorec,et al. Challenges with advanced therapy medicinal products and how to meet them , 2010, Nature Reviews Drug Discovery.
[28] Yao‐Hua Song,et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. , 2007, European heart journal.
[29] Jeff W M Bulte,et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[30] F. Mouquet,et al. CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation , 2005, Circulation research.
[31] Giulio Cossu,et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.
[32] Stefan Wagner,et al. Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.
[33] G. Puddu,et al. Surgical treatment for early osteoarthritis. Part II: allografts and concurrent procedures , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.
[34] Haris S. Vasiliadis,et al. Autologous Chondrocyte Implantation , 2010, The American journal of sports medicine.
[35] P. Menasché. Skeletal myoblasts for cardiac repair: Act II? , 2008, Journal of the American College of Cardiology.
[36] B. Strauer,et al. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.
[37] C. Ohlsson,et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.
[38] A. Gratwohl,et al. Predictability of hematopoietic stem cell transplantation rates , 2007, Haematologica.
[39] A. Gratwohl. Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT) , 1991, Bone marrow transplantation.
[40] B. Horisberger,et al. Current trends in hematopoietic stem cell transplantation in Europe. , 2002, Blood.
[41] Cell Therapy for Peripheral Arterial Disease , 2017 .
[42] Richard T. Lee,et al. Stem-cell therapy for cardiac disease , 2008, Nature.
[43] J. McMurray,et al. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. , 2006, The American journal of cardiology.
[44] A. Zeiher,et al. Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.
[45] A. Terzic,et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.
[46] Hong Wang,et al. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis , 2009, Multiple sclerosis.
[47] M. Marcacci,et al. Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.
[48] R. Mahfouz,et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study , 2010, Journal of Neuroimmunology.
[49] G. Behre,et al. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L , 2008, Leukemia.
[50] O. Alfieri,et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.
[51] René Verdonk,et al. Treatment of Cartilage Defects in the Knee Using Alginate Beads Containing Human Mature Allogenic Chondrocytes , 2009, The American journal of sports medicine.
[52] Ivan Martin,et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation , 2012, Journal of cellular physiology.
[53] F. Luyten,et al. Five-Year Outcome of Characterized Chondrocyte Implantation Versus Microfracture for Symptomatic Cartilage Defects of the Knee , 2011, The American journal of sports medicine.
[54] Meijing Wang,et al. Stem cell therapy in myocardial repair and remodeling. , 2008, Journal of the American College of Surgeons.
[55] Jeroen J. Bax,et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. , 2009, JAMA.
[56] Marcus F Stoddard,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.
[57] J. Hare,et al. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.
[58] J. Bellemans,et al. Repair of symptomatic cartilage lesions of the knee: the place of autologous chondrocyte implantation. , 2007, Acta orthopaedica Belgica.
[59] N. Guseva,et al. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. , 2008, Rheumatology.
[60] P. Wernet,et al. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. , 2001, Deutsche medizinische Wochenschrift.
[61] F. Carrión,et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients , 2010, Lupus.
[62] A. Di Stefani,et al. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. , 2011, Stem cell research.
[63] P. Menasché. Stem cell therapy for heart failure: are arrhythmias a real safety concern? , 2009, Circulation.
[64] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[65] A. Zeiher,et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[66] A. Gratwohl,et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies , 2009, Bone Marrow Transplantation.